{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:20:26Z","timestamp":1793017226177,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.jinf.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T19:19:43Z","timestamp":1563218383000},"page":"228-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals"],"prefix":"10.1016","volume":"79","author":[{"given":"Portia M.","family":"Manngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gutschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice I.","family":"Snyders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hygon","family":"Mutavhatsindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Manyelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nonjabulo S.","family":"Makhoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri","family":"Ahlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriette","family":"Hiemstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley","family":"McAnda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanus T.","family":"Malherbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Walzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novel N.","family":"Chegou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2019.07.007_bib0001","unstructured":"WHO|Global tuberculosis report 2018 [WWW Document], 2018. WHO. URL http:\/\/www.who.int\/tb\/publications\/global_report\/en."},{"issue":"4","key":"10.1016\/j.jinf.2019.07.007_bib0002","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/eri.11.23","article-title":"Tuberculosis assays: past, present and future","volume":"9","author":"Chegou","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/j.jinf.2019.07.007_bib0003","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","article-title":"Tuberculosis: advances and challenges in development of new diagnostics and biomarkers","volume":"18","author":"Walzl","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2019.07.007_bib0004","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1590\/s1806-37562017000000219","article-title":"Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey","volume":"43","author":"Amicosante","year":"2017","journal-title":"J Bras Pneumol: Publ Off Soc Bras Pneumol Tisil"},{"key":"10.1016\/j.jinf.2019.07.007_bib0005","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JCM.37.3.748-752.1999","article-title":"Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria","volume":"37","author":"Hanna","year":"1999","journal-title":"J Clin Microbial"},{"key":"10.1016\/j.jinf.2019.07.007_bib0006","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1183\/09031936.00147507","article-title":"Novel tests for diagnosing tuberculous pleural effusion: what works and what does not?","volume":"31","author":"Trajman","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2019.07.007_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/eri.11.23","article-title":"Tuberculosis assays: past, present and future","volume":"9","author":"Chegou","year":"2011","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"10.1016\/j.jinf.2019.07.007_bib0008","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000128575","article-title":"Evaluation of adapted whole-blood Interferon-\u03b3 release assays for the diagnosis of pleural tuberculosis","volume":"76","author":"Chegou","year":"2008","journal-title":"Respiration"},{"key":"10.1016\/j.jinf.2019.07.007_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clinbiochem.2015.08.013","article-title":"Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa","volume":"49","author":"Corstjens","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jinf.2019.07.007_bib0010","series-title":"Use of Tuberculosis Interferon-Gamma Release Assays (IGRAS) in Low- and Middle-Income Countries: A Policy Statement","year":"2011"},{"key":"10.1016\/j.jinf.2019.07.007_bib0011","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2334-12-10","article-title":"Potential of novel mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting","volume":"12","author":"Chegou","year":"2012","journal-title":"BMC Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2019.07.007_bib0012","doi-asserted-by":"crossref","first-page":"e38501","DOI":"10.1371\/journal.pone.0038501","article-title":"Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area","volume":"7","author":"Chegou","year":"2012","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.jinf.2019.07.007_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102584","article-title":"Host cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease","volume":"9","author":"Essone","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2019.07.007_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-9-21","article-title":"Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report","volume":"9","author":"Chegou","year":"2009","journal-title":"BMC Pulm Med"},{"issue":"5","key":"10.1016\/j.jinf.2019.07.007_bib0015","doi-asserted-by":"crossref","first-page":"e64226","DOI":"10.1371\/journal.pone.0064226","article-title":"Utility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting","volume":"8","author":"Chegou","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jinf.2019.07.007_bib0016","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tube.2011.02.006","article-title":"Discriminating between latent and active tuberculosis with multiple biomarker responses","volume":"91","author":"Frahm","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"issue":"11","key":"10.1016\/j.jinf.2019.07.007_bib0017","doi-asserted-by":"crossref","first-page":"e26545","DOI":"10.1371\/journal.pone.0026545","article-title":"Multiple cytokines are released when blood from patients with tuberculosis is stimulated with mycobacterium tuberculosis antigens","volume":"6","author":"Kellar","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2019.07.007_bib0018","unstructured":"QuantiFERON\u00ae-TB Gold Plus, ELISA Package Insert, QUIAGEN. http:\/\/www.quantiferon.com\/irm\/content\/PI\/QFT\/PLUS\/2PK-Elisa\/UK.pdf."},{"key":"10.1016\/j.jinf.2019.07.007_bib0019","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","article-title":"First evaluation of QuantiFERON-TB Gold Plus performance in contact screening","volume":"48","author":"Barcellini","year":"2016","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.jinf.2019.07.007_bib0020","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1183\/09031936.00151413","article-title":"Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with mycobacterium tuberculosis","volume":"43","author":"Chegou","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jinf.2019.07.007_bib0021","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tube.2018.06.005","article-title":"Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection","volume":"111","author":"Petrone","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"issue":"8","key":"10.1016\/j.jinf.2019.07.007_bib0022","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.cmi.2016.05.006","article-title":"Equal sensitivity of the new generation QuantiFERON-TB gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT","volume":"22","author":"Hoffmann","year":"2016","journal-title":"Clin Microbiol Infec"},{"key":"10.1016\/j.jinf.2019.07.007_bib0023","doi-asserted-by":"crossref","unstructured":"Chegou, N.N., Sutherland, J.S., Malherbe, S., Crampin, A.C., Corstjens, P.L.A.M., Geluk, A. et al. Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax. 2016; 71, 785\u2013794","DOI":"10.1136\/thoraxjnl-2015-207999"},{"issue":"7","key":"10.1016\/j.jinf.2019.07.007_bib0024","doi-asserted-by":"crossref","first-page":"e2535","DOI":"10.1371\/journal.pone.0002535","article-title":"Evaluation of commercial fluorescent bead-based luminex cytokine assays","volume":"3","author":"Djoba Siawaya","year":"2008","journal-title":"PLoS ONE"},{"issue":"36","key":"10.1016\/j.jinf.2019.07.007_bib0025","doi-asserted-by":"crossref","first-page":"57581","DOI":"10.18632\/oncotarget.11420","article-title":"Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response","volume":"7","author":"Jacobs","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jinf.2019.07.007_bib0026","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/s41598-018-20855-7","article-title":"Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis","volume":"8","author":"Chegou","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jinf.2019.07.007_bib0028","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/JCM.01646-16","article-title":"Highly multiplexed proteomic analysis of quantiferon supernatants to identify biomarkers of latent tuberculosis infection","volume":"55","author":"Groote","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2019.07.007_bib0029","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jinf.2016.04.036","article-title":"Evaluation of cytokine responses against novel MTB antigens as diagnostic markers for TB disease","volume":"73","author":"Awoniyi","year":"2016","journal-title":"J Infect."},{"key":"10.1016\/j.jinf.2019.07.007_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/981984","article-title":"Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis","author":"Phalane","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jinf.2019.07.007_bib0031","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10096-018-3258-y","article-title":"Recent advances in tuberculosis diagnostics in resource-limited settings","volume":"37","author":"Seki","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"10.1016\/j.jinf.2019.07.007_bib0032","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/B978-0-7234-3691-1.00033-7","article-title":"9-Cytokines and cytokine receptors","volume":"2013","author":"O'Shea","year":"2013","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2019.07.007_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192664","article-title":"Identification of plasma biomarkers for discrimination between tuberculosis infection\/disease and pulmonary non tuberculosis disease","volume":"13","author":"La Manna","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2019.07.007_bib0034","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tube.2018.08.011","article-title":"Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting j","volume":"114","author":"Clifford","year":"2019","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.jinf.2019.07.007_bib0035","doi-asserted-by":"crossref","unstructured":"Li, CY., Chen, HC., Cheng, HY., Chian, CF., Chang, FY., Chen, HI. et al. Role of Quantiferon-TB-Gold in tube assay for active and latent tuberculosis infection in investigation of tuberculosis outbreak in a university. 2015; 48(3):263\u20138.","DOI":"10.1016\/j.jmii.2013.08.022"},{"issue":"6","key":"10.1016\/j.jinf.2019.07.007_bib0036","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jinf.2016.09.008","article-title":"First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus","volume":"73","author":"Petruccioli","year":"2018","journal-title":"J Infect."},{"key":"10.1016\/j.jinf.2019.07.007_bib0037","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tube.2017.06.002","article-title":"Analytical evaluation of QuantiFERON- Plus and QuantiFERON- Gold In-tube assays in subjects with or without tuberculosis","volume":"106","author":"Petruccioli","year":"2017","journal-title":"Tuberculosis."},{"issue":"6417","key":"10.1016\/j.jinf.2019.07.007_bib0038","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/362248a0","article-title":"Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses","volume":"362","author":"Minty","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jinf.2019.07.007_bib0039","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tube.2017.04.005","article-title":"Chemokinesadditional to IFN-\u03b3 can be used to differentiate among mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype","volume":"105","author":"Nonghanphithak","year":"2017","journal-title":"Tuberculosis."},{"key":"10.1016\/j.jinf.2019.07.007_bib0040","first-page":"2193","article-title":"Granulocyte-Macrophage colony-stimulating factor as a therapeutic target in multiple sclerosis","author":"Aram","year":"2018","journal-title":"Neurol Ther"},{"issue":"2","key":"10.1016\/j.jinf.2019.07.007_bib0041","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1172\/JCI116623","article-title":"Inflammatory roles of P-selectin","volume":"92","author":"Lorant","year":"1993","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jinf.2019.07.007_bib0042","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1128\/iai.64.8.2917-2922.1996","article-title":"Epidermal growth factor binding protein in mycobacterium avium and mycobacterium tuberculosis: a possible role in the mechanism of infection","volume":"64","author":"Bermudez","year":"1996","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.jinf.2019.07.007_bib0043","first-page":"169","article-title":"Use of several immunological markers to model the probability of active tuberculosis","volume":"86","year":"2016","journal-title":"Epub"},{"issue":"3","key":"10.1016\/j.jinf.2019.07.007_bib0044","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jinf.2016.11.010","article-title":"Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease","volume":"74","author":"Won","year":"2017","journal-title":"J Infect"},{"issue":"6","key":"10.1016\/j.jinf.2019.07.007_bib0045","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jinf.2018.09.011","article-title":"Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children","volume":"77","author":"Sali","year":"2018","journal-title":"J Infect"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319302178?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319302178?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:27:10Z","timestamp":1759008430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319302178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0163445319302178"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.07.007","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}